INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD
1. Pomerantz LLP investigates potential securities fraud claims against 3D Systems. 2. 3D Systems missed Q4 2024 sales and earnings estimates, triggering stock drop. 3. Healthcare revenue fell by 21% due to accounting changes in Regenerative Medicine. 4. Stock price declined by 20.96% to $2.15 per share following the announcements.